| Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma BA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NB Dahir, ... Journal of clinical oncology: official journal of the American Society of …, 2015 | 341 | 2015 |
| The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma A Mikulasova, CP Wardell, A Murison, EM Boyle, GH Jackson, J Smetana, ... Haematologica 102 (9), 1617-1625, 2017 | 46 | 2017 |
| Gain (1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib J Smetana, K Berankova, R Zaoralova, P Nemec, H Greslikova, R Kupska, ... Clinical Lymphoma Myeloma and Leukemia 13 (2), 123-130, 2013 | 24 | 2013 |
| Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience J Smetana, J Frohlich, R Zaoralova, V Vallova, H Greslikova, R Kupska, ... BioMed research international 2014, 2014 | 21 | 2014 |
| Genomewide profiling of copy‐number alteration in monoclonal gammopathy of undetermined significance A Mikulasova, J Smetana, M Wayhelova, H Janyskova, V Sandecka, ... European journal of haematology 97 (6), 568-575, 2016 | 16 | 2016 |
| Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma A Mikulasova, C Ashby, RG Tytarenko, P Qu, A Rosenthal, JA Dent, ... haematologica 105 (4), 1055-1066, 2020 | 11 | 2020 |
| Prediction of progression of smouldering into therapy requiring multiple myeloma by easily accessible clinical factors [in 527 patients] R Hajek, V Sandecka, A Seckinger, I Spicka, V Scudla, E Gregora, ... Blood, The Journal of the American Society of Hematology 124 (21), 2071-2071, 2014 | 11 | 2014 |
| Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2 CJA Duncan, BJ Thompson, R Chen, GI Rice, F Gothe, DF Young, ... Science Immunology 4 (42), 2019 | 9 | 2019 |
| A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance V Sandecká, R Hájek, L Pour, I Špička, V Ščudla, E Gregora, J Radocha, ... European Journal of Haematology 99 (1), 80-90, 2017 | 7 | 2017 |
| Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH J Smetana, E Dementyeva, F Kryukov, P Nemec, H Greslikova, R Kupska, ... Neoplasma 61 (1), 48-55, 2014 | 6 | 2014 |
| Analysis of B-cell subpopulations in monoclonal gammopathies P Všianská, L Říhová, T Varmužová, R Suská, F Kryukov, A Mikulášová, ... Clinical Lymphoma Myeloma and Leukemia 15 (4), e61-e71, 2015 | 5 | 2015 |
| Germline TET2 Loss-Of-Function Causes Childhood Immunodeficiency And Lymphoma J Stremenova Spegarova, D Lawless, SMB Mohamad, KR Engelhardt, ... Blood, 2020 | 4 | 2020 |
| Exome sequencing to define a genetic signature of plasma cells in systemic AL amyloidosis EM Boyle, BA Walker, D Rowczienio, CP Wardell, A Murison, ... Blood, The Journal of the American Society of Hematology 124 (21), 726-726, 2014 | 3 | 2014 |
| Germline TET2 Loss-Of-Function Causes Childhood Immunodeficiency And Lymphoma. D Lawless, SMB Mohamad, KR Engelhardt, GM Doody, J Shrimpton, ... Blood, 2020 | 1 | 2020 |
| Chromothripsis and chromoplexy are associated with DNA instability and adverse clinical outcome in multiple myeloma C Ashby, MA Bauer, Y Wang, CP Wardell, RG Tytarenko, P Patel, E Flynt, ... Blood 132 (Supplement 1), 408-408, 2018 | 1 | 2018 |
| Intragenic DNA-hypomethylation promotes overexpression of ITGB7 in MF subgroup of multiple myeloma SR Choudhury, C Ashby, R Tytarenko, Y Wang, PH Patel, A Mikulasova, ... Cancer Research 78 (13 Supplement), 5324-5324, 2018 | 1 | 2018 |
| Whole genome sequencing reveals the extent of structural variants in multiple myeloma and identifies recurrent mutational hotspots within the non-coding regions CC Ashby, M Bauer, OW Stephens, CP Wardell, RG Tytarenko, ... Blood 130 (Supplement 1), 3032-3032, 2017 | 1 | 2017 |
| Case Report Clonal cytogenetics changes in progression of multiple myeloma to extramedullary relapse and plasmocellular leukemia: a case report J Smetana, P Kuglik, H Greslikova, R Kupska, P Nemec, A Mikulasova, ... Int J Clin Exp Pathol 9 (1), 49-60, 2016 | 1 | 2016 |
| Whole genome amplification effect on segmental copy-number changes and copy-number neutral loss of heterozygosity analysis by oligonucleotide-array based comparative genomic … A Mikulášová, J Smetana, M Wayhelova, H Peschelová, SA Okubote, ... | 1 | 2016 |
| Exome sequencing and SNP arrays as a tool to describe genetic diversity of premalignant and malignant cells: lesson from monoclonal gammopathies A Mikulasova, BA Walker, CP Wardell, EM Boyle, M Wayhelova, ... CHROMOSOME RESEARCH 23, S33-S34, 2015 | 1 | 2015 |
